Robert B. Rebhun

3.7k total citations
95 papers, 1.9k citations indexed

About

Robert B. Rebhun is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Robert B. Rebhun has authored 95 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 26 papers in Genetics and 23 papers in Molecular Biology. Recurrent topics in Robert B. Rebhun's work include Veterinary Oncology Research (45 papers), Immunotherapy and Immune Responses (17 papers) and Virus-based gene therapy research (15 papers). Robert B. Rebhun is often cited by papers focused on Veterinary Oncology Research (45 papers), Immunotherapy and Immune Responses (17 papers) and Virus-based gene therapy research (15 papers). Robert B. Rebhun collaborates with scholars based in United States, South Korea and Brazil. Robert B. Rebhun's co-authors include Katherine A. Skorupski, Carlos O. Rodriguez, Michael S. Kent, William T. N. Culp, Sara D. Allstadt, Isaiah J. Fidler, Sita S. Withers, Robert J. Canter, Jenna H. Burton and Daniel York and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Robert B. Rebhun

90 papers receiving 1.8k citations

Peers

Robert B. Rebhun

PRM

GENET

ONCOL

D. J. Argyle United Kingdom

E. van Garderen Netherlands

Valentina Zappulli Italy

M. Caniatti Italy

H. Gerber Switzerland

Munekazu NAKAICHI Japan

Sina Bartfeld Germany

Serenella Papparella Italy

Krista M. D. La Perle United States

L. Morrison United Kingdom

D. J. Argyle United Kingdom

Robert B. Rebhun

608 ×0.7

PRM

285 ×0.6

GENET

415 ×0.8

339 ×0.8

ONCOL

336 ×0.9

Citations per year, relative to Robert B. Rebhun Robert B. Rebhun (= 1×) peers D. J. Argyle

Countries citing papers authored by Robert B. Rebhun

Since Specialization

Citations

This map shows the geographic impact of Robert B. Rebhun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Rebhun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Rebhun more than expected).

Fields of papers citing papers by Robert B. Rebhun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Rebhun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Rebhun. The network helps show where Robert B. Rebhun may publish in the future.

Co-authorship network of co-authors of Robert B. Rebhun

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Rebhun. A scholar is included among the top collaborators of Robert B. Rebhun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Rebhun. Robert B. Rebhun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grandis, Jennifer R., Katherine A. Skorupski, Ning Cheng, et al.. (2025). Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer. Cancer Cell. 43(11). 2051–2068.e9. 2 indexed citations

Harris, H., Sean J. Judge, Marshall Lammers, et al.. (2024). Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. Journal for ImmunoTherapy of Cancer. 12(4). e007963–e007963. 4 indexed citations

Rebhun, Robert B., et al.. (2023). Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs. Veterinary and Comparative Oncology. 21(4). 717–725. 1 indexed citations

Soltero‐Rivera, Maria, Kristen Wong, Robert B. Rebhun, et al.. (2023). The diagnostic yield of preoperative screening for oral cancer in dogs over 15 years, part 1: locoregional screening. Journal of the American Veterinary Medical Association. 261(S2). S14–S23. 3 indexed citations

Culp, William T. N., Eric G. Johnson, Michelle A. Giuffrida, et al.. (2022). Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs. PLoS ONE. 17(8). e0269941–e0269941. 2 indexed citations

Willcox, Jennifer L., et al.. (2022). Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma. Veterinary and Comparative Oncology. 21(1). 20–27.

Johnson, Eric G., Carrie A. Palm, Jenna H. Burton, et al.. (2022). MRI characteristics of canine prostatic neoplasia. Veterinary Radiology & Ultrasound. 64(1). 105–112. 3 indexed citations

Griffin, Maureen A., William T. N. Culp, & Robert B. Rebhun. (2021). Canine and feline haemangiosarcoma. Veterinary Record. 189(9). e585–e585. 24 indexed citations

Withers, Sita S., Hong Chang, Justin A. Spanier, et al.. (2020). Development of canine PD-1/PD-L1 specific monoclonal antibodies and amplification of canine T cell function. PLoS ONE. 15(7). e0235518–e0235518. 30 indexed citations

10.

Withers, Sita S., Katherine A. Skorupski, Daniel York, et al.. (2018). Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma. Veterinary and Comparative Oncology. 17(1). 49–60. 37 indexed citations

11.

Withers, Sita S., Daniel York, Eric G. Johnson, et al.. (2018). In vitro and in vivo activity of liposome‐encapsulated curcumin for naturally occurring canine cancers. Veterinary and Comparative Oncology. 16(4). 571–579. 18 indexed citations

12.

Mansour, Tamer, Sara E. Konopelski, Peter J. Dickinson, et al.. (2018). Whole genome variant association across 100 dogs identifies a frame shift mutation in DISHEVELLED 2 which contributes to Robinow-like syndrome in Bulldogs and related screw tail dog breeds. PLoS Genetics. 14(12). e1007850–e1007850. 58 indexed citations

13.

Vernau, William, et al.. (2017). Patient characteristics, prognostic factors and outcome of dogs with high‐grade primary mediastinal lymphoma. Veterinary and Comparative Oncology. 16(1). E45–E51. 12 indexed citations

14.

Burton, Jenna H., Scott D. Stanley, Heather K. Knych, et al.. (2015). Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer. Journal of Veterinary Internal Medicine. 30(1). 242–246. 20 indexed citations

15.

Allstadt, Sara D., et al.. (2015). Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First-Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs. Journal of Veterinary Internal Medicine. 29(1). 261–267. 45 indexed citations

16.

Shahi, Mehdi Hayat, Idoya Zazpe, Mohammad Afzal, et al.. (2014). Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples. Tumor Biology. 36(4). 2383–2391. 12 indexed citations

17.

Shahi, Mehdi Hayat, et al.. (2014). Blocking Signaling at the Level of GLI Regulates Downstream Gene Expression and Inhibits Proliferation of Canine Osteosarcoma Cells. PLoS ONE. 9(5). e96593–e96593. 21 indexed citations

18.

Balhorn, Rod, et al.. (2010). A selective high affinity ligand (SHAL) designed to bind to an over-expressed human antigen on non-Hodgkin's lymphoma also binds to canine B-cell lymphomas. Veterinary Immunology and Immunopathology. 137(3-4). 235–242. 4 indexed citations

19.

Rebhun, Robert B., Susan E. Lana, E. J. Ehrhart, J. B. Charles, & Douglas H. Thamm. (2008). Comparative Analysis of Survivin Expression in Untreated and Relapsed Canine Lymphoma. Journal of Veterinary Internal Medicine. 22(4). 989–995. 29 indexed citations

20.

Rebhun, Robert B., Robert R. Langley, Kenji Yokoi, et al.. (2006). Targeting Receptor Tyrosine Kinase on Lymphatic Endothelial Cells for the Therapy of Colon Cancer Lymph Node Metastasis. Neoplasia. 8(9). 747–757. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact